SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.8%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$1.42M
AUM Growth
+$1.42M
(+65%)
Cap. Flow
+$1.17M
Cap. Flow
% of AUM
82.19%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
200
New
33
Increased
31
Reduced
36
Closed
37
Top Buys
| 1 |
Pfizer
PFE
|
$39.1K |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$27.4K |
| 3 |
Merck
MRK
|
$12K |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$11.6K |
| 5 |
Gilead Sciences
GILD
|
$10.7K |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$16.4K |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.99K |
| 3 |
Tesla
TSLA
|
$7.93K |
| 4 |
Larimar Therapeutics
LRMR
|
$6.67K |
| 5 |
Ocular Therapeutix
OCUL
|
$4.66K |
Sector Composition
| 1 | Healthcare | 20.45% |
| 2 | Energy | 0.93% |
| 3 | Industrials | 0.31% |
| 4 | Consumer Staples | 0.23% |
| 5 | Technology | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$141B
| $39.1K | 1.23% | +1,254,894 | New | +$39.1K |
|
|
2
Acadia Pharmaceuticals
ACAD
$4.38B
| $27.4K | 0.87% | +864,437 | New | +$27.4K |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $16.8K | 0.53% | 65,181 +2,948 | +5% | +$759 |
|
4
AstraZeneca
AZN
$248B
| $13.5K | 0.43% | 192,055 -23,268 | -11% | -$1.64K |
|
|
IOC
5
DELISTED
Interoil Corporation
IOC
| $13.2K | 0.42% | 270,330 +46,351 | +21% | +$2.26K |
|
|
ACHN
6
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $12.3K | 0.39% | 1,004,187 +946,216 | +1,632% | +$11.6K |
|
|
7
Merck
MRK
$210B
| $12K | 0.38% | +211,130 | New | +$12K |
|
|
8
Gilead Sciences
GILD
$140B
| $10.7K | 0.34% | +113,260 | New | +$10.7K |
|
9
Tenax Therapeutics
TENX
$27.3M
| $9.03K | 0.29% | 2,350,567 -449,933 | -16% | -$1.73K |
|
10
Carisma Therapeutics
CARM
$8.98M
| $8.29K | 0.26% | 697,470 +677,473 | +3,388% | +$8.05K |
|
11
Adverum Biotechnologies
ADVM
$64.6M
| $7.71K | 0.24% | 142,803 +92,803 | +186% | +$5.01K |
|
|
BLCM
12
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $7.64K | 0.24% | +331,515 | New | +$7.64K |
|
13
Agilent Technologies
A
$35.7B
| $6.76K | 0.21% | +165,008 | New | +$6.76K |
|
|
COV
14
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $6.7K | 0.21% | 65,537 -1,215 | -2% | -$124 |
|
|
DERM
15
DELISTED
Dermira, Inc.
DERM
| $6.38K | 0.2% | +352,088 | New | +$6.38K |
|
|
RGLS
16
DELISTED
Regulus Therapeutics
RGLS
| $5.65K | 0.18% | +352,278 | New | +$5.65K |
|
17
ProQR Therapeutics
PRQR
$237M
| $5.48K | 0.17% | 253,083 -128,166 | -34% | -$2.78K |
|
18
Microbot Medical
MBOT
$185M
| $5.44K | 0.17% | 5,793,994 +967,611 | +20% | +$909 |
|
|
CDMO
19
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.2K | 0.16% | +237,797 | New | +$5.2K |
|
20
Danaher
DHR
$147B
| $4.72K | 0.15% | +55,053 | New | +$4.72K |
|
21
MannKind Corp
MNKD
$1.41B
| $4.49K | 0.14% | 860,751 +275,833 | +47% | +$1.44K |
|
22
Sangamo Therapeutics
SGMO
$157M
| $4.46K | 0.14% | 293,500 -126,623 | -30% | -$1.93K |
|
23
Quest Resource Holding
QRHC
$38.5M
| $4.35K | 0.14% | 3,017,925 +694,142 | +30% | +$1K |
|
|
THMO
24
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $3.78K | 0.12% | 3,701,695 +150,614 | +4% | +$154 |
|
25
Puma Biotechnology
PBYI
$254M
| $3.57K | 0.11% | +18,860 | New | +$3.57K |
|